{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:41Z","timestamp":1786982861058,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007253","name":"Nancy Taylor Foundation for Chronic Diseases","doi-asserted-by":"publisher","award":["5105042007"],"award-info":[{"award-number":["5105042007"]}],"id":[{"id":"10.13039\/100007253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40744-023-00628-z","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T06:01:36Z","timestamp":1702101696000},"page":"143-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adalimumab Effectively Decreases Inflammation Downstream of TNF\u03b1 Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-2645","authenticated-orcid":false,"given":"Megan M.","family":"Simonds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Freer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Al-Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnneMarie C.","family":"Brescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"issue":"5","key":"628_CR1","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/art.38336","volume":"66","author":"AC Brescia","year":"2014","unstructured":"Brescia AC, Simonds MM, McCahan SM, Fawcett PT, Rose CD. The role of transforming growth factor beta signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor beta signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthr Rheumatol. 2014;66(5):1352\u201362.","journal-title":"Arthr Rheumatol"},{"issue":"1","key":"628_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"issue":"10","key":"628_CR3","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25(10):1991\u20134.","journal-title":"J Rheumatol"},{"issue":"2","key":"628_CR4","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"1","key":"628_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9(1):24\u201333.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"628_CR6","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1038\/s41598-021-98651-z","volume":"11","author":"K Koedderitzsch","year":"2021","unstructured":"Koedderitzsch K, Zezina E, Li L, Herrmann M, Biesemann N. TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A. Sci Rep. 2021;11(1):19385.","journal-title":"Sci Rep"},{"issue":"4","key":"628_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.26","volume":"8","author":"J-W Lee","year":"2017","unstructured":"Lee J-W, Lee J, Um SH, Moon E-Y. Synovial cell death is regulated by TNF-\u03b1-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1\u03b1. Cell Death Dis. 2017;8(4):e2727.","journal-title":"Cell Death Dis"},{"issue":"26","key":"628_CR8","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1126\/sciadv.aba4353","volume":"6","author":"MND Svensson","year":"2020","unstructured":"Svensson MND, Zoccheddu M, Yang S, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6(26):4353.","journal-title":"Sci Adv"},{"issue":"2","key":"628_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008312","volume":"16","author":"A Arbu\u00e9s","year":"2020","unstructured":"Arbu\u00e9s A, Brees D, Chibout SD, Fox T, Kamm\u00fcller M, Portevin D. TNF-\u03b1 antagonists differentially induce TGF-\u03b21-dependent resuscitation of dormant-like Mycobacterium tuberculosis. PLoS Pathog. 2020;16(2):e1008312.","journal-title":"PLoS Pathog"},{"issue":"3","key":"628_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1365-2249.2002.01785.x","volume":"127","author":"H Cheon","year":"2002","unstructured":"Cheon H, Yu SJ, Yoo DH, Chae IJ, Song GG, Sohn J. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol. 2002;127(3):547\u201352.","journal-title":"Clin Exp Immunol"},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.phrs.2016.11.025","volume":"115","author":"Z Szondy","year":"2017","unstructured":"Szondy Z, Pallai A. Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: therapeutic implications. Pharmacol Res. 2017;115:124\u201332.","journal-title":"Pharmacol Res"},{"issue":"1","key":"628_CR12","first-page":"146","volume":"36","author":"A Adrovic","year":"2021","unstructured":"Adrovic A, Yildiz M, K\u00f6ker O, \u015eahin S, Barut K, Kasap\u00e7opur \u00d6. Biologics in juvenile idiopathic arthritis-main advantages and major challenges: a narrative review. Arch Rheumatol. 2021;36(1):146\u201357.","journal-title":"Arch Rheumatol"},{"key":"628_CR13","doi-asserted-by":"crossref","unstructured":"Al-Jaberi L, Simonds MM, Brescia AC. CCL24, CXCL9, and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment. Rheumatology (Oxford). 2023;62(7):2594\u20132600.","DOI":"10.1093\/rheumatology\/keac617"},{"issue":"3","key":"628_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/rheumatology\/kep358","volume":"49","author":"L Pattacini","year":"2010","unstructured":"Pattacini L, Boiardi L, Casali B, Salvarani C. Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford). 2010;49(3):480\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"628_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/art.38336","volume":"66","author":"AC Brescia","year":"2014","unstructured":"Brescia AC, Simonds MM, McCahan SM, Fawcett PT, Rose CD. The role of transforming growth factor \u03b2 signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor \u03b2 signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthr Rheumatol. 2014;66(5):1352\u201362.","journal-title":"Arthr Rheumatol"},{"issue":"8","key":"628_CR16","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.4049\/jimmunol.1500502","volume":"196","author":"M Charbonneau","year":"2016","unstructured":"Charbonneau M, Lavoie RR, Lauzier A, Harper K, McDonald PP, Dubois CM. Platelet-derived growth factor receptor activation promotes the prodestructive invadosome-forming phenotype of synoviocytes from patients with rheumatoid arthritis. J Immunol. 2016;196(8):3264\u201375.","journal-title":"J Immunol"},{"issue":"1","key":"628_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1465-9921-7-125","volume":"7","author":"S Mukhopadhyay","year":"2006","unstructured":"Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF\u03b1 in pulmonary pathophysiology. Respir Res. 2006;7(1):125.","journal-title":"Respir Res"},{"key":"628_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942417","author":"DE Mahmoud","year":"2022","unstructured":"Mahmoud DE, Kaabachi W, Sassi N, et al. The synovial fluid fibroblast-like synoviocyte: a long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.942417.","journal-title":"Front Immunol"},{"issue":"6","key":"628_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16(6):316\u201333.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"628_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","volume":"23","author":"G van Loo","year":"2023","unstructured":"van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nat Rev Immunol. 2023;23(5):289\u2013303.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"628_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41584-020-0455-8","volume":"16","author":"H Anderton","year":"2020","unstructured":"Anderton H, Wicks IP, Silke J. Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease. Nat Rev Rheumatol. 2020;16(9):496\u2013513.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"628_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","volume":"37","author":"AT Ting","year":"2016","unstructured":"Ting AT, Bertrand MJM. More to Life than NF-\u03baB in TNFR1 signaling. Trends Immunol. 2016;37(8):535\u201345.","journal-title":"Trends Immunol"},{"issue":"3","key":"628_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tcb.2019.12.009","volume":"30","author":"T Delanghe","year":"2020","unstructured":"Delanghe T, Dondelinger Y, Bertrand MJM. RIPK1 kinase-dependent death: a symphony of phosphorylation events. Trends Cell Biol. 2020;30(3):189\u2013200.","journal-title":"Trends Cell Biol"},{"issue":"8b","key":"628_CR24","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1582-4934.2008.00647.x","volume":"13","author":"DE Sullivan","year":"2009","unstructured":"Sullivan DE, Ferris M, Nguyen H, Abboud E, Brody AR. TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med. 2009;13(8b):1866\u201376.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"628_CR25","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang DI, Lee AH, Shin HY, et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"628_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14(1):397\u2013440.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"628_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","volume":"49","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Transmembrane TNF-\u03b1: structure, function and interaction with anti-TNF agents. Rheumatology. 2010;49(7):1215\u201328.","journal-title":"Rheumatology"},{"key":"628_CR28","doi-asserted-by":"crossref","unstructured":"Reddy SP, Lin EJ, Shah VV, Wu JJ. Chapter 10 - Adalimumab. In: Wu JJ, Feldman SR, Lebwohl MG, editors. Therapy for severe psoriasis: Elsevier; 2016. p. 111\u201326.","DOI":"10.1016\/B978-0-323-44797-3.00010-4"},{"issue":"1","key":"628_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13075-022-02721-0","volume":"24","author":"DD Gladman","year":"2022","unstructured":"Gladman DD, Coates LC, Wu J, et al. Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo. Arthritis Res Ther. 2022;24(1):40.","journal-title":"Arthritis Res Ther"},{"key":"628_CR30","doi-asserted-by":"crossref","unstructured":"Berkhout LC, l'Ami MJ, Ruwaard J, et al. Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Sci Transl Med. 2019;11(477):eaat3356.","DOI":"10.1126\/scitranslmed.aat3356"},{"key":"628_CR31","doi-asserted-by":"crossref","unstructured":"Paccalet A, Crola Da Silva C, Mechtouff L, et al. Serum soluble tumor necrosis factor receptors 1 and 2 are early prognosis markers after ST-segment elevation myocardial infarction. Front Pharmacol. 2021;12:656928.","DOI":"10.3389\/fphar.2021.656928"},{"key":"628_CR32","doi-asserted-by":"crossref","unstructured":"Webster JD, Vucic D. The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front Cell Develop Biol. 2020;8:365.","DOI":"10.3389\/fcell.2020.00365"},{"issue":"7","key":"628_CR33","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/cdd.2017.46","volume":"24","author":"M Lork","year":"2017","unstructured":"Lork M, Verhelst K, Beyaert R. CYLD, A20 and OTULIN deubiquitinases in NF-\u03baB signaling and cell death: so similar, yet so different. Cell Death Differ. 2017;24(7):1172\u201383.","journal-title":"Cell Death Differ"},{"key":"628_CR34","doi-asserted-by":"crossref","unstructured":"Interferon gamma. In: Aronson JK, editor. Meyler\u2019s side effects of drugs. 16th ed. Oxford: Elsevier; 2016. p. 220\u20132.","DOI":"10.1016\/B978-0-444-53717-1.00902-1"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-023-00628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-023-00628-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-023-00628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T10:32:44Z","timestamp":1705573964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-023-00628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s40744-023-00628-z","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Megan Simonds, Samuel Freer, Lina Al-Jaberi, and AnneMarie Brescia declare that they have no competing interests and no interests to disclose. All author affiliations at the time of the study are accurate on the title page; however, Samuel Freer is now affiliated with the University of Texas as a graduate student and Lina Al-Jaberi is now affiliated with Arkansas Children\u2019s Hospital after completing her fellowship at Nemours Children\u2019s Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Synovial fluid and fibroblast-like synoviocyte samples were obtained from the Nemours BioMedical Institutional Review Board-approved repository (IRB#84709-32). This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. Patients who underwent clinically indicated arthrocentesis were offered inclusion into the repository and informed consent was obtained. There is no identifying information in this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}